Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKACA | P17612 | 1/20 | 0.36 |
| ▸ | PRKACG | P22612 | 1/20 | 0.36 |
| ▸ | PRKACB | P22694 | 1/20 | 0.36 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.34 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.34 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.33 |
| ▸ | RBP4 | P02753 | 4/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.30 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31444320 | 0.87 | OPRL1 (0.38) | KCNH2OPRL1CYP2A13RBP4KDM4E | |
| Hydrochloric Acid SCHEMBL31444540 | 0.83 | HTR2C (0.39) | PRKACAPRKACGPRKACBCSNK1DCSNK1E | |
| SCHEMBL31444605 | 0.79 | MEN1 (0.39) | PRKACAPRKACGPRKACBCSNK1DCSNK1E | |
| SCHEMBL31444533 | 0.78 | CSNK1D (0.36) | PRKACAPRKACGPRKACBCSNK1DCSNK1E | |
| SCHEMBL20319860 | 0.78 | TAAR1 (0.38) | PRKACAPRKACGPRKACBOPRL1 | |
| Hydrochloric Acid SCHEMBL31444535 | 0.76 | HTR2A (0.39) | PRKACAPRKACGPRKACBOPRL1 | |
| SCHEMBL31444396 | 0.76 | OPRL1 (0.43) | OPRL1CHRNB2CHRNA4KDM4E | |
| SCHEMBL22456404 | 0.76 | PDCD1LG2 (0.45) | OPRL1CHRNB2CHRNA4 | |
| SCHEMBL31444536 | 0.76 | PDCD1LG2 (0.45) | OPRL1CHRNB2CHRNA4 | |
| SCHEMBL27885732 | 0.76 | PRKACA (0.36) | PRKACAPRKACGPRKACBCSNK1DCSNK1E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072451-A1 | RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES | VIVIDION THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |